| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.18 | 0.3 |